## OTIS: Otis Worldwide Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 2.17 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($85.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Otis Fourth Quarter and Full Year 2025 Earnings Advisory**
- Source: Finviz | 20260107T141006 | Neutral | Relevance: 100%
- Otis Worldwide Corporation (NYSE: OTIS) will host a conference call on Wednesday, January 28, 2026, at 8:30 a.m. ET to discuss its fourth quarter and full year 2025 results and provide a 2026 outlook. The call will feature Otis Chair, CEO & President Judy Marks and Executive Vice President & CFO Cristina Mendez, with a webcast option available for investors. A corresponding presentation and news release will precede the call on www.otis.com, where a recording will also be available later.

**2. Otis Worldwide's Quarterly Earnings Preview: What You Need to Know**
- Source: Barchart.com | 20260107T140606 | Somewhat-Bullish | Relevance: 100%
- Otis Worldwide (OTIS) is set to announce its Q4 2025 earnings, with analysts expecting a 9.7% rise in profit to $1.02 per share. The company has a history of surpassing Wall Street estimates and saw its shares surge after better-than-expected Q3 results. Despite underperforming the S&P 500, analysts hold a "Moderate Buy" rating with a target indicating a 14.8% potential upside.

**3. Investment Research & Advisory Group Inc. Cuts Stake in Otis Worldwide Corporation $OTIS**
- Source: MarketBeat | 20260105T125155 | Somewhat-Bullish | Relevance: 100%
- Investment Research & Advisory Group Inc. significantly reduced its stake in Otis Worldwide Corporation by 93.9% in Q3 2025, selling 19,637 shares and retaining 1,281 shares valued at $118,000. Additionally, Otis CAO Michael Patrick Ryan sold 3,028 shares, decreasing his personal holdings by over 53%. Despite these sales, Otis reported strong Q3 EPS, provided optimistic FY2025 guidance, and analysts maintain a "Hold" consensus rating with a target price of $103.50.

**4. Otis Worldwide Corporation (NYSE:OTIS) Given Average Rating of "Hold" by Analysts**
- Source: MarketBeat | 20260105T074433 | Neutral | Relevance: 100%
- Eleven analysts have given Otis Worldwide Corporation (NYSE:OTIS) an average rating of "Hold," with a consensus one-year target price of $103.50. The company recently reported Q3 EPS of $1.05 and revenue of $3.69 billion, beating analyst estimates, and provided FY 2025 EPS guidance in line with expectations. Institutional investors have been actively trading OTIS shares, with a significant increase in holdings by some firms.

**5. Lab automation specialist Scinomix joins Ingersoll Randâ€™s life sciences arm**
- Source: Stock Titan | 20260105T213157 | Neutral | Relevance: 63%
- Ingersoll Rand (NYSE: IR) has acquired Scinomix, a U.S.-based designer and manufacturer of lab automation technologies, to expand its life sciences portfolio. This acquisition integrates Scinomix into Ingersoll Rand's Precision and Science Technologies Life Sciences platform, aiming to provide comprehensive, end-to-end solutions for sample management and lab equipment automation. The deal was made at an attractive pre-synergy multiple of approximately 10x 2025 Adjusted EBITDA.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Wells Fargo | $92 | $95 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Wells Fargo | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.88M) |
| Sells | 2 ($0.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.1%)
- Blackrock Inc.: 8.2% (-1.3%)
- Alliancebernstein L.: 4.3% (-12.6%)
- State Street Corpora: 4.1% (-0.2%)
- JPMORGAN CHASE & CO: 3.9% (-32.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.17 elevated, pricing in significant growth expectations. Quality metrics strong (ROA 14%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $34.7B |
| Beta | 1.01 |
| 52W Range | $84.25 - $106.83 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.17 |
| Forward P/E | 19.8 |
| Current P/E | 21.7 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.3% (minimal 5-day change). Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 51. OFD pattern: -FTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.32% (CS: 47) | Neutral |
| RSI_14 | 51.0 | Neutral |
| MACD Histogram | 0.23 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 0.956x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $88.41
- **Stop Loss:** $85.77 (3.0% risk)
- **Target:** $91.05 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 284
- **Position Value:** $25,108.44
- **Portfolio %:** 25.11%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-01-28 (Est: $1.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.00 | $1.05 | +4.7% |
| 2025Q2 | $1.03 | $1.05 | +2.1% |
| 2025Q1 | $0.91 | $0.92 | +1.1% |
| 2024Q4 | $0.96 | $0.93 | -2.8% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_10*